bioRxivNeurosciencePreprint
Platelets from early-stage Alzheimer patients show enhanced amyloid binding, an elevated open canalicular system and sex-specific differences in their activation profile
Lili Donner, Julia ChristliD, Milenko KujoviciD, Tillmann SupprianiD, Margitta ElversiD
Abstract
IntroductionAlzheimers disease (AD) is associated with neurodegeneration and dementia. The clinical parameters include the deposition of amyloid-{beta} into senile plaques in the brain parenchyma and in cerebral vessels known as cerebral amyloid angiopathy (CAA). Currently, {beta}-amyloid-antibodies are emerging as possible therapy for AD. Several biomarkers, such as {beta}-Amyloid and tau-protein have gained significant value for diagnosing early AD. However, these biomarkers require cerebrospinal fluid. Blood tests for screening of AD are urgently needed. MethodsPatients diagnosed with early AD were analyzed for extracellular amyloid-{beta} binding to platelets, platelet morphology and platelet activation and compared to age-matched controls. ResultsBeside unaltered platelet number and size, we detected increased binding of amyloid-{beta} to activated platelets isolated from AD patients. Electron microscopy revealed an altered platelet morphology in AD patients including the number of dense granules and the area of the open canalicular system (OCS) as compared to controls. While only minor differences in platelet activation were detected between patients and controls, a significant reduction of integrin IIb{beta}3 (fibrinogen receptor) activation was evident in platelets from female compared to male AD patients as determined by flow cytometry. ConclusionThe here presented results emphasize the importance to increase our understanding how platelets contribute to AD pathology in patients in a sex-specific manner. Furthermore, platelet parameters might serve as an ideal biomarker for a first prognosis of AD because platelets can be easily accessed by blood samples. These parameters might include a sex-specific platelet activation profile, the capability to bind A{beta} to the platelet surface and the dimension of the OCS by electron microscopy.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Platelet phosphorylated TDP-43: An exploratory study for a peripheral surrogate biomarker development for Alzheimer’s disease
RODGER E WILHITE, Jessica M. Sage, … Abdulbaki Aǵbaş·Future Science OAPeer-reviewed·Aug 16, 2017
- Early beta-amyloid accumulation in the brain is associated with peripheral T cell alterations
C. Gericke, T. Kirabali, … A. Gietl·bioRxiv·Jan 17, 2023
- Soluble amyloid-beta buffering by plaques in Alzheimer disease dementia versus high-pathology controls
Thomas J. Esparza, Mihika Gangolli, … David L. Brody·PLoS ONEPeer-reviewed·Jul 6, 2018
- Platelet proteolytic machinery assessment in Alzheimer's Disease
Roy G. Muriu, Jessica M. Sage, Abdulbaki Aǵbaş·Journal of Unexplored Medical DataPeer-reviewed·Feb 14, 2020
- Senile plaques in Alzheimer's disease arise from Aβ and Cathepsin D-enriched amyloidogenic mixtures out of intravascular hemolysis and Charcot-Bouchard aneurysm-related vascular degeneration
- Spatiotemporal Characterization of Amyloidosis-Associated Microglial States Reveals Sex Difference in Early Plaque Formation
Amritha Vinayak Manjally, Abigail Fowler, … Tuan Leng Tay·bioRxiv·Aug 31, 2026